Renin angiotensin system gene polymorphisms and cerebral blood flow regulation: The MOBILIZE boston study

Stroke

Volumn 41, Issue 4, 2010, Pages 635-640

  Hajjar, Ihab ^a   Sorond, Farzaneh ^b   Hsu, Yi Hsiang ^a   Galica, Andrew ^a   Cupples, L Adrienne ^c   Lipsitz, Lewis A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Cerebral blood flow; Cerebral hemodynamics; Gene regulation; Renin angiotensin

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; CYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE; THREONINE;

AGE DISTRIBUTION; AGED; AGING; ARTICLE; AUTOREGULATION; BODY MASS; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CLINICAL TRIAL; COMMUNITY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; GAIT; GENDER; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOCAPNIA; INTELLECT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PHENOTYPE; PRIORITY JOURNAL; REFERENCE VALUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SITTING; STANDING; STROKE; TREATMENT OUTCOME; UNITED STATES; VASODILATATION;

ADULT; AGED; ANGIOTENSINOGEN; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; HOUSING FOR THE ELDERLY; HUMANS; NEUROPSYCHOLOGICAL TESTS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTORS, ANGIOTENSIN; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; RENIN-ANGIOTENSIN SYSTEM; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77950280749     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.572669     Document Type: Article

References (38)

1. Lipsitz LA, Mukai S, Hamner J, Gagnon M, Babikian V. Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke. 2000;31:1897-1903.
2. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Trans-cranial Doppler hemodynamic parameters and risk of stroke: the Rotterdam Study. Stroke. 2007;38:2453-2458.
3. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57:789-794.
4. Saavedra JM, Nishimura Y. Angiotensin and cerebral blood flow. Cell Mol Neurobiol. 1999;19:553-573.
5. Rose JM, Audus KL. Receptor-mediated angiotensin II transcytosis by brain microvessel endothelial cells. Peptides. 1998;19:1023-1030.
6. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke. 2000;31:2478-2486.
7. Ito T, Yamakawa H, Bregonzio C, Terron JA, Falcon-Neri A, Saavedra JM. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angio-tensin II AT1 antagonist. Stroke. 2002;33:2297-2303.
8. Yamakawa H, Jezova M, Ando H, Saavedra JM. Normalization of endo-thelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab. 2003;23:371-380.
9. Buchanan JE, Phillis JW. The role of nitric oxide in the regulation of cerebral blood flow. Brain Res. 1993;610:248-255.
10. Barbalic M, Skaric-Juric T, Cambien F, Barbaux S, Poirier O, Turek S, Vrhovski-Hebrang D, Cubrilo-Turek M, Rudan I, Rudan P, Narancic NS. Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Am J Hypertens. 2006;19:837-842.
11. Ylitalo A, Airaksinen KE, Hautanen A, Kupari M, Carson M, Virolainen J, Savolainen M, Kauma H, Kesaniemi YA, White PC, Huikuri HV. Baroreflex sensitivity and variants of the renin angiotensin system genes. J Am Coll Cardiol. 2000;35:194-200.
12. Snieder H, Harshfield GA, Treiber FA. Heritability of blood pressure and hemodynamics in African-and European American youth. Hypertension. 2003;41:1196-1201.
13. Samelson EJ, Kelsey JL, Kiel DP, Roman AM, Cupples LA, Freeman MB, Jones RN, Hannan MT, Leveille SG, Gagnon MM, Lipsitz LA. Issues in conducting epidemiologic research among elders: lessons from the MOBILIZE Boston Study. Am J Epidemiol. 2008;168:1444-1451.
14. Leveille SG, Kiel DP, Jones RN, Roman A, Hannan MT, Sorond FA, Kang HG, Samelson EJ, Gagnon M, Freeman M, Lipsitz LA. The MOBILIZE Boston Study: design and methods of a prospective cohort study of novel risk factors for falls in an older population. BMC Geriatr. 2008;8:16.
15. Anthony JC, LeResche L, Niaz U, von Korff MR, Folstein MF. Limits of the 'Mini-Mental State' as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397-408.
16. Sorond FA, Khavari R, Serrador JM, Lipsitz LA. Regional cerebral autoregulation during orthostatic stress: age-related differences. J Gerontol A Biol Sci Med Sci. 2005;60:1484-1487.
17. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Dopp-ler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769-774.
18. Hetzel A, Braune S, Guschlbauer B, Dohms K. CO2 reactivity testing without blood pressure monitoring? Stroke. 1999;30:398-401.
19. Ringelstein EB, Sievers C, Ecker S, Schneider PA, Otis SM. Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke. 1988; 19:963-969.
20. Bishop CC, Powell S, Insall M, Rutt D, Browse NL. Effect of internal carotid artery occlusion on middle cerebral artery blood flow at rest and in response to hypercapnia. Lancet. 1986;1:710-712.
21. Claassen JA, Zhang R, Fu Q, Witkowski S, Levine BD. Transcranial Doppler estimation of cerebral blood flow and cerebrovascular conductance during modified rebreathing. J Appl Physiol. 2007;102: 870-877.
22. Sorond FA, Serrador JM, Jones RN, Shaffer ML, Lipsitz LA. The sit-to-stand technique for the measurement of dynamic cerebral auto-regulation. Ultrasound Med Biol. 2009;35:21-29.
23. Mollsten A, Stegmayr B, Wiklund PG. Genetic polymorphisms in the renin-angiotensin system confer increased risk of stroke independently of blood pressure: a nested case-control study. J Hypertens. 2008;26: 1367-1372.
24. Castellano M, Glorioso N, Cusi D, Sarzani R, Fabris B, Opocher G, Zoccali C, Golin R, Veglio F, Volpe M, Mantero F, Fallo F, Rossi GP, Barlassina C, Tizzoni L, Filigheddu F, Giacche M, Rossi F. Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER project. J Hypertens. 2003;21:1853-1860.
25. Dudbridge F, Koeleman BP. Rank truncated product of P-values, with application to genomewide association scans. Genet Epidemiol. 2003;25: 360-366.
26. Saab YB, Gard PR, Yeoman MS, Mfarrej B, El-Moalem H, Ingram MJ. Renin-angiotensin-system gene polymorphisms and depression. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1113-1118.
27. van Rijn MJ, Bos MJ, Isaacs A, Yazdanpanah M, Arias-Vasquez A, Stricker BH, Klungel OH, Oostra BA, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM, van Duijn CM. Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosurg Psychiatry. 2007;78:1083-1087.
28. Vicenzini E, Ricciardi MC, Altieri M, Puccinelli F, Bonaffini N, Di Piero V, Lenzi GL. Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study. Eur Neurol. 2007;58:84-89.
29. Lavi S, Gaitini D, Milloul V, Jacob G. Impaired cerebral CO2 vasoreac-tivity: association with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2006;291:H1856-H1861.
30. Lavi S, Egbarya R, Lavi R, Jacob G. Role of nitric oxide in the regulation of cerebral blood flow in humans: chemoregulation versus mechanoregu-lation. Circulation. 2003;107:1901-1905.
31. Niwa K, Lindauer U, Villringer A, Dirnagl U. Blockade of nitric oxide synthesis in rats strongly attenuates the CBF response to extracellular acidosis. J Cereb Blood Flow Metab. 1993;13:535-539.
32. Bari F, Errico RA, Louis TM, Busija DW. Interaction between ATP-sensitive k+ channels and nitric oxide on pial arterioles in piglets. J Cereb Blood Flow Metab. 1996;16:1158-1164.
33. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002;90: E58-E65.
34. Rainbow RD, Norman RI, Everitt DE, Brignell JL, Davies NW, Standen NB. Endothelin-I and angiotensin II inhibit arterial voltage-gated k + channels through different protein kinase c isoenzymes. Cardiovasc Res. 2009;83:493-500.
35. Dusting GJ, Staszewska-Barczak J. Humoral response and blood pressure regulation during hypercapnia and hemorrhage in dogs. Clin Sci Mol Med Suppl. 1976;3:165s-168s.
36. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated met235-thr allele of the human angioten-sinogen gene. Hum Mol Genet. 1993;2:609-610.
37. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
38. Eames PJ, Blake MJ, Panerai RB, Potter JF. Cerebral autoregulation indices are unimpaired by hypertension in middle aged and older people. Am J Hypertens. 2003;16:746-753.